Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1778

1.

Nonvitamin-K-antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and previous stroke or transient ischemic attack: An updated systematic review and meta-analysis of randomized controlled trials.

Ntaios G, Papavasileiou V, Diener HC, Makaritsis K, Michel P.

Int J Stroke. 2017 Aug;12(6):589-596. doi: 10.1177/1747493017700663. Epub 2017 Mar 15.

PMID:
28730948
2.

Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.

Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M.

J Am Heart Assoc. 2017 Jul 18;6(7). pii: e005835. doi: 10.1161/JAHA.117.005835. Review.

3.

Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Ntaios G, Papavasileiou V, Makaritsis K, Vemmos K, Michel P, Lip GYH.

Stroke. 2017 Jul 17. pii: STROKEAHA.117.017549. doi: 10.1161/STROKEAHA.117.017549. [Epub ahead of print]

PMID:
28716982
4.

Non-vitamin K oral anticoagulants are non-inferior for stroke prevention but cause fewer major bleedings than well-managed warfarin: A retrospective register study.

Sjögren V, Byström B, Renlund H, Svensson PJ, Oldgren J, Norrving B, Själander A.

PLoS One. 2017 Jul 10;12(7):e0181000. doi: 10.1371/journal.pone.0181000. eCollection 2017.

5.

[Non vitamin-K dependent oral anticoagulants (NOACs) in chronic kidney disease patients with non-valvular atrial fibrillation].

Di Lullo L, Barbera V, Bellasi A, Cozzolino M, Russo D, Otranto G, Santoboni F, Ronco C.

G Ital Nefrol. 2017 Apr;34(2):58-73. Italian.

PMID:
28682563
6.

[NOACs and Chronic kidney disease].

Di Lullo L, Barbera V, Bellasi A, Cozzolino M, Russo D, Otranto G, Santoboni F, Ronco C.

G Ital Nefrol. 2017 Mar;34(Suppl 69):188-204. Italian.

PMID:
28682039
8.

Effectiveness and Safety of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-Analyses.

Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH.

Clin Ther. 2017 Jun 28. pii: S0149-2918(17)30699-9. doi: 10.1016/j.clinthera.2017.05.358. [Epub ahead of print] Review.

PMID:
28668628
9.

Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Patients With Nonvalvular Atrial Fibrillation and Previous Stroke or Transient Ischemic Attack.

Coleman CI, Peacock WF, Bunz TJ, Alberts MJ.

Stroke. 2017 Aug;48(8):2142-2149. doi: 10.1161/STROKEAHA.117.017474. Epub 2017 Jun 27.

PMID:
28655814
10.

Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?

Kuo L, Chao TF, Liu CJ, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, Liao JN, Chung FP, Chen TJ, Lip GYH, Chen SA.

J Am Heart Assoc. 2017 Jun 23;6(6). pii: e005307. doi: 10.1161/JAHA.116.005307.

11.

Efficacy and Safety of Rivaroxaban Versus Warfarin in Patients Taking Nondihydropyridine Calcium Channel Blockers for Atrial Fibrillation (from the ROCKET AF Trial).

Washam JB, Hellkamp AS, Lokhnygina Y, Piccini JP, Berkowitz SD, Nessel CC, Becker RC, Breithardt G, Fox KAA, Halperin JL, Hankey GJ, Mahaffey KW, Singer DE, Patel MR; ROCKET AF Steering Committee and Investigators.

Am J Cardiol. 2017 May 29. pii: S0002-9149(17)30862-7. doi: 10.1016/j.amjcard.2017.05.026. [Epub ahead of print]

PMID:
28645473
12.

Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials.

Wang KL, Chiu CC, Su-Yin Tan D, Lin CY, Lai EY, Goto S, Giugliano RP, Chiang CE.

J Formos Med Assoc. 2017 Jun 20. pii: S0929-6646(17)30146-8. doi: 10.1016/j.jfma.2017.05.015. [Epub ahead of print]

13.

The Efficacy and Safety of 3 Types of Interventions for Stroke Prevention in Patients With Cardiovascular and Cerebrovascular Diseases: A Network Meta-analysis.

Sun Q, Chang S, Lu S, Zhang Y, Chang Y.

Clin Ther. 2017 Jun 10. pii: S0149-2918(17)30243-6. doi: 10.1016/j.clinthera.2017.04.008. [Epub ahead of print]

PMID:
28606562
14.

An integrated epidemiological and neural net model of the warfarin effect in managed care patients.

Jacobs DM, Stefanovic F, Wilton G, Gomez-Caminero A, Schentag JJ.

Clin Pharmacol. 2017 May 18;9:55-64. doi: 10.2147/CPAA.S136243. eCollection 2017.

15.

Lesson of the month 2: Contusion confusion.

Wood H, Mayes T, King S, Kasznia-Brown J, Solanki T.

Clin Med (Lond). 2017 Jun;17(3):282-283. doi: 10.7861/clinmedicine.17-3-282.

PMID:
28572234
16.

Drug therapy in anticoagulation: which drug for which patient?

Millar CM, Laffan MA.

Clin Med (Lond). 2017 Jun;17(3):233-244. doi: 10.7861/clinmedicine.17-3-233.

PMID:
28572224
17.

Intracerebral haemorrhage risk in microbleed-positive ischaemic stroke patients with atrial fibrillation: Preliminary meta-analysis of cohorts and anticoagulation decision schema.

Charidimou A, Boulouis G, Shams S, Calvet D, Shoamanesh A; International META-MICROBLEEDS Initiative.

J Neurol Sci. 2017 Jul 15;378:102-109. doi: 10.1016/j.jns.2017.04.042. Epub 2017 Apr 28.

PMID:
28566143
18.

Stroke in Patients with Chronic Kidney Disease…: How do we Approach and Manage it?

Nayak-Rao S, Shenoy MP.

Indian J Nephrol. 2017 May-Jun;27(3):167-171. doi: 10.4103/0971-4065.202405. Review.

19.

Adjuncts to Blood Component Therapies for the Treatment of Bleeding in the Intensive Care Unit.

Levy JH, Ghadimi K, Quinones QJ, Bartz RR, Welsby I.

Transfus Med Rev. 2017 Apr 25. pii: S0887-7963(17)30012-3. doi: 10.1016/j.tmrv.2017.04.001. [Epub ahead of print] Review.

PMID:
28552276
20.

Warfarin and the Risk of Stroke and Bleeding in Patients With Atrial Fibrillation Receiving Dialysis: A Systematic Review and Meta-analysis.

Harel Z, Chertow GM, Shah PS, Harel S, Dorian P, Yan AT, Saposnik G, Sood MM, Molnar AO, Perl J, Wald RM, Silver S, Wald R.

Can J Cardiol. 2017 Jun;33(6):737-746. doi: 10.1016/j.cjca.2017.02.004. Epub 2017 Feb 20. Review.

PMID:
28545622

Supplemental Content

Loading ...
Support Center